Cargando…

Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation

Detalles Bibliográficos
Autores principales: Dimou, Anastasios, Ou, Sai-Hong I., Doebele, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450917/
https://www.ncbi.nlm.nih.gov/pubmed/32914039
http://dx.doi.org/10.1200/PO.19.00013
_version_ 1783574885649350656
author Dimou, Anastasios
Ou, Sai-Hong I.
Doebele, Robert C.
author_facet Dimou, Anastasios
Ou, Sai-Hong I.
Doebele, Robert C.
author_sort Dimou, Anastasios
collection PubMed
description
format Online
Article
Text
id pubmed-7450917
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-74509172020-09-09 Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation Dimou, Anastasios Ou, Sai-Hong I. Doebele, Robert C. JCO Precis Oncol Case Report American Society of Clinical Oncology 2019-06-03 /pmc/articles/PMC7450917/ /pubmed/32914039 http://dx.doi.org/10.1200/PO.19.00013 Text en © 2019 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
spellingShingle Case Report
Dimou, Anastasios
Ou, Sai-Hong I.
Doebele, Robert C.
Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation
title Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation
title_full Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation
title_fullStr Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation
title_full_unstemmed Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation
title_short Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation
title_sort dramatic response to lorlatinib in a patient with cd74-ros1-positive lung adenocarcinoma with acquired f2004v mutation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450917/
https://www.ncbi.nlm.nih.gov/pubmed/32914039
http://dx.doi.org/10.1200/PO.19.00013
work_keys_str_mv AT dimouanastasios dramaticresponsetolorlatinibinapatientwithcd74ros1positivelungadenocarcinomawithacquiredf2004vmutation
AT ousaihongi dramaticresponsetolorlatinibinapatientwithcd74ros1positivelungadenocarcinomawithacquiredf2004vmutation
AT doebelerobertc dramaticresponsetolorlatinibinapatientwithcd74ros1positivelungadenocarcinomawithacquiredf2004vmutation